• PDF / 188,040 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 61 Downloads / 156 Views

DOWNLOAD

REPORT

20/0863-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 3 Oct 2020 No. 863

1

Recommend Documents

Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment

171 54 617KB

Fixed-dosage monoclonal antibodies save costs

156 62 184KB

Treatment costs of attention deficit hyperactivity disorder in Germany

173 50 217KB

Biosimilars in der Gastroenterologie

181 71 224KB

Save the Forests: Use More Wood

151 62 16MB

Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany

132 25 1MB

Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Ce

143 64 729KB

Adjuvant Therapy in Patients with Colorectal Cancer

150 36 13MB

Alcohol, Tobacco, and Substance Use and Association with Opioid Use Disorder in Patients with Non-malignant and Cancer P

170 90 312KB

Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studi

171 49 1008KB

Biosimilars

155 25 276KB

Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and

181 33 1MB